本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Mersana Therapeutics Inc.

27.83
-0.0900-0.32%
成交量:10.35万
成交额:287.17万
市值:1.39亿
市盈率:-1.86
高:28.05
开:27.60
低:27.54
收:27.92
52周最高:70.73
52周最低:5.21
股本:499.88万
流通股本:375.34万
量比:0.23
换手率:2.76%
股息:- -
股息率:- -
每股收益(TTM):-14.9441
每股收益(LYR):-14.1163
净资产收益率:-505.14%
总资产收益率:-34.11%
市净率:-2.62
市盈率(LYR):-1.97

数据加载中...

2024/10/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/13

重要事件披露

Form 8-K - Current report
2024/06/11

重要事件披露

Form 8-K - Current report
2024/05/17

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities